Corpus Intelligence IC Memo — ENCOMPASS HEALTH REHABILITATION HOSP 2026-04-26 09:36 UTC
IC Memo — ENCOMPASS HEALTH REHABILITATION HOSP
Investment Committee Memorandum | VA | 58 beds | Grade C | EBITDA uplift $2.4M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ENCOMPASS HEALTH REHABILITATION HOSP

CCN 493032 | SPOTSYLVANIA, VA | 58 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

ENCOMPASS HEALTH REHABILITATION HOSP is a 58-bed suburban community hospital in SPOTSYLVANIA, VA with $32.1M in net patient revenue and a 17.9% operating margin. The hospital serves a payer mix of 59.3% Medicare, 0.7% Medicaid, and 40.0% commercial.

Thesis: Turnaround. Our ML models identify $2.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 17.9% to 25.3% (+736bps).

Net Revenue HCRIS$32.1M
Current EBITDA COMPUTED$5.8M
Operating Margin COMPUTED17.9%
Occupancy HCRIS90.2%
Revenue / Bed COMPUTED$553K
Net-to-Gross HCRIS73.2%
Distress Probability ML45.0%

2. Market Context & Competitive Position

111
VA Hospitals
4.4%
State Median Margin
53
Comparable Hospitals

VA has 111 Medicare-certified hospitals with a median operating margin of 4.4%. The target's margin of 17.9% places it above the state median. Among 53 size-comparable peers (29-116 beds), the median margin is 5.7%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (29-116), prioritizing same-state peers. 53 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ENCOMPASS HEALTH REHABILITATIO (Target)VA58$32.1M17.9%
CARILION NEW RIVER VALLEY MED VA94$261.3M-0.5%
RICHMOND COMMUNITY HOSPITALVA96$254.9M21.5%
UVA HEALTH PRINCE WILLIAM MEDIVA106$191.7M-7.4%
JOHNSTON MEMORIAL HOSPITALVA100$188.3M6.1%
MARY IMMACULATE HOSPITALVA114$184.6M0.8%
LONESOME PINE HOSPITALVA56$175.6M17.2%
LEWISGALE HOSPITAL - MONTGOMERVA92$155.7M40.7%
CULPEPER MEMORIAL HOSPITALVA70$153.9M9.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.4M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$674K+210bp18mo
Cost to Collect4.5%2.5%$641K+200bp12mo
Denial Rate Reduction12.0%6.5%$635K+198bp12mo
A/R Days Reduction5200.0%3800.0%$390K+122bp9mo
Clean Claim Rate88.0%96.0%$21K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$674K
Cost to Collect
$641K
Denial Rate Reduction
$635K
A/R Days Reduction
$390K
Clean Claim Rate
$21K
Total EBITDA Uplift$2.4M
Current EBITDA$5.8M
+ RCM Uplift+$2.4M
Pro Forma EBITDA$8.1M
Current Margin17.9%
Pro Forma Margin25.3%
WC Released (1x)$1.2M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$8.8M$61.5M6.96x47.4%
Base (11x exit)10.0x11.0x$8.8M$70.6M7.98x51.5%
Bull Case9.0x11.0x$8.0M$81.2M10.20x59.1%
Bull (12x exit)9.0x12.0x$8.0M$91.0M11.42x62.8%
Bear Case11.0x10.0x$9.7M$46.9M4.82x36.9%
Bear (11x exit)11.0x11.0x$9.7M$54.7M5.62x41.2%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 59.3% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 53 hospitals with 29-116 beds
  • Same-state prioritization (n=54)
  • Comp margins: P25=-9.7% / P50=5.7% / P75=15.0%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.